Skip to main content

Table 4 Demographic and clinical characteristics association with outcome

From: Response to prone positioning in COVID-19 patients with acute respiratory distress syndrome: a retrospective observational study

Variable

Outcome

Sig

Died

Survived

Agea

58.3 ± 16.2

64.61 ± 14.0

0.11

Age groupsb

40 years and below

0 (0)

7 (13.5)

0.151

41–60 years

8 (34.8)

19 (36.5)

 > 60 years

15 (65.2)

26 (50)

Genderb

Male

12 (52.2)

38 (73.1)

0.080

Female

11 (47.8)

14 (26.9)

Smokingb

No

13 (65.5)

28 (53.8)

0.830

Yes

10 (43.5)

24 (46.2)

Comorbidityb

No

4 (17.4)

10 (19.2)

0.850

Yes

19 (82.6)

42 (80.8)

Comorbidity numberc

2 [2]

1 [1]

0.292

CHASD-Vasc scorec

2 [3]

1 [1]

0.068

CHASD-Vasc riskb

Low

5 (21.7)

16 (30.8)

0.014*

Low-moderate

1 (4.3)

15 (28.8)

High-moderate

17 (73.9)

21 (40.4)

Hypertensionb

No

11 (47.8)

36 (69.2)

0.080

Yes

12 (52.2)

16 (30.8)

Diabetesb

No

14 (60.9)

31 (59.6)

0.910

Yes

9 (39.1)

21 (40.4)

ARDS severityb

Mild

0 (0)

3 (5.8)

0.382

Moderate

16 (69.6)

38 (75)

Severe

7 (30.4)

11 (19.2)

Intubationb

No

7 (30.4)

37 (71.2)

0.001*

Yes

16 (69.6)

15 (28.8)

O2 responseb

Yes

7 (30.4)

24 (46.2)

0.202

No

16 (69.6)

28 (53.8)

CO2 responseb

Yes

8 (34.8)

21 (40.4)

0.646

No

15 (65.2)

31 (59.6)

  1. Data are presented as mean ± standard deviation, number (%), or median [interquartile range]
  2. ARDS Acute respiratory distress syndrome, CHA2DS2-VASc Congestive heart failure, hypertension, age > 75, diabetes, prior stroke/transient ischemic attack, and vascular disease history, O2 Oxygen, CO2 Carbon dioxide
  3. aIndependent samples t-test
  4. bChi-square test
  5. cMann-Whitney U test
  6. *Significant